Current Environment: Production

Kira Bona | Education

Graduate School

Harvard T.H. Chan School of Public Health

Boston, MA

Medical School

Yale University School of Medicine

New Haven, CT

Residency

Boston Combined Residency Program (BCRP)

Boston, MA

Fellowship

Pediatric Hematology-Oncology

Boston Children's Hospital / Dana-Farber Cancer Institute

Boston, MA

Kira Bona | Certifications

  • American Board of Pediatrics (General)

Kira Bona | Professional History

Dr. Kira Bona received her MD from the Yale University School of Medicine and her MPH from the Harvard T.H. Chan School of Public Health with a focus on clinical effectiveness. She completed her pediatrics residency in the Boston Combined Residency Program (BCRP) at Boston Children’s Hospital and Boston Medical Center and her pediatric hematology/oncology subspecialty fellowship training at Dana-Farber Cancer Institute/Boston Children’s Hospital. She joined the faculty at Dana-Farber/Boston Children’s as a pediatric oncologist in 2012. In addition to her role in the treatment of children with leukemia and lymphoma, Dr. Bona is a physician-scientist with research focused on identifying poverty-associated outcome disparities in childhood cancer and developing interventions to ameliorate these disparities. Dr. Bona has been the recipient of several past awards and honors including a Young Investigator Award from the American Society of Clinical Oncology, a St. Baldrick’s Fellow Award, a Junior Faculty Career Development Award from the National Palliative Care Research Center, a Charles H. Hood Child Health Research Grant, and an NCI K07 Mentored Career Development Award.

Kira Bona | Publications

  1. Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report. J Natl Cancer Inst. 2024 Oct 01; 116(10):1664-1674. View Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report. Abstract

  2. Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronly versus paired tumor-normal sequencing. Haematologica. 2024 Sep 01; 109(9):3024-3030. View Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronly versus paired tumor-normal sequencing. Abstract

  3. Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia Outcomes. Res Sq. 2024 Aug 16. View Impact of Genetic Ancestry on T-cell Acute Lymphoblastic Leukemia Outcomes. Abstract

  4. Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort. Pediatr Blood Cancer. 2024 Nov; 71(11):e31274. View Supplemental Nutrition Assistance Program participation gaps within a pediatric leukemia clinical trial cohort. Abstract

  5. Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Pediatr Blood Cancer. 2024 Oct; 71(10):e31192. View Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trials. Abstract

  6. Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer. 2024 Nov 15; 130(22):3785-3796. View Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Abstract

  7. Household material hardship and distress among parents of children with advanced cancer: A report from the PediQUEST Response trial. Cancer. 2024 Oct 15; 130(20):3540-3548. View Household material hardship and distress among parents of children with advanced cancer: A report from the PediQUEST Response trial. Abstract

  8. Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2024 Jul; 71(7):e31051. View Enrollment on upfront high-risk neuroblastoma trials by race, ethnicity, and poverty status: A report from the Children's Oncology Group. Abstract

  9. Providing Groceries and Transportation to Poverty-Exposed Pediatric Oncology Families: The PediCARE Pilot Randomized Clinical Trial. JAMA Netw Open. 2024 May 01; 7(5):e2412890. View Providing Groceries and Transportation to Poverty-Exposed Pediatric Oncology Families: The PediCARE Pilot Randomized Clinical Trial. Abstract

  10. Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research. Cancer Med. 2024 Apr; 13(7):e6966. View Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research. Abstract

  11. Inequitable Poverty Exposures: A Subspecialty Opportunity to Address Disparities. Hosp Pediatr. 2024 02 01; 14(2):e104-e106. View Inequitable Poverty Exposures: A Subspecialty Opportunity to Address Disparities. Abstract

  12. Prescription for Cash? Cash Support to Low-Income Families in Maternal and Pediatric Health Care Settings. Milbank Q. 2024 03; 102(1):64-82. View Prescription for Cash? Cash Support to Low-Income Families in Maternal and Pediatric Health Care Settings. Abstract

  13. Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia. J Natl Cancer Inst. 2023 10 09; 115(10):1179-1187. View Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia. Abstract

  14. Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30592. View Children's Oncology Group's 2023 blueprint for research: Diversity and health disparities. Abstract

  15. Gaps in Parental Understanding of Sleep Disturbances During Maintenance Therapy for Pediatric Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol Nurs. 2023 Nov-Dec; 40(6):369-378. View Gaps in Parental Understanding of Sleep Disturbances During Maintenance Therapy for Pediatric Acute Lymphoblastic Leukemia. Abstract

  16. "It's a lot of things": Household material hardship among Black and Hispanic parents of children with cancer. Pediatr Blood Cancer. 2023 Jun 13; e30485. View "It's a lot of things": Household material hardship among Black and Hispanic parents of children with cancer. Abstract

  17. Association of unmet basic resource needs with frailty and quality of life among older adults with cancer-Results from the CARE registry. Cancer Med. 2023 06; 12(12):13846-13855. View Association of unmet basic resource needs with frailty and quality of life among older adults with cancer-Results from the CARE registry. Abstract

  18. Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. Blood. 2023 02 09; 141(6):609-619. View Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy. Abstract

  19. Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials. Lancet Haematol. 2023 Feb; 10(2):e129-e141. View Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials. Abstract

  20. Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease. J Clin Oncol. 2023 04 20; 41(12):2227-2237. View Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease. Abstract

  21. Addressing Social Determinants of Health: Now Is the Time. J Natl Cancer Inst. 2022 12 08; 114(12):1561-1563. View Addressing Social Determinants of Health: Now Is the Time. Abstract

  22. "The simple life experiences that every other human gets": Desire for normalcy among adolescents and young adults with advanced cancer. Pediatr Blood Cancer. 2023 01; 70(1):e30035. View "The simple life experiences that every other human gets": Desire for normalcy among adolescents and young adults with advanced cancer. Abstract

  23. Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium. J Pediatr Hematol Oncol Nurs. 2023 Jan-Feb; 40(1):17-23. View Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium. Abstract

  24. Feasibility of oncology clinical trial-embedded evaluation of social determinants of health. Pediatr Blood Cancer. 2022 11; 69(11):e29933. View Feasibility of oncology clinical trial-embedded evaluation of social determinants of health. Abstract

  25. Rationale and design of Children's Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States. BMC Health Serv Res. 2022 Jun 28; 22(1):832. View Rationale and design of Children's Oncology Group (COG) study ACCL20N1CD: financial distress during treatment of acute lymphoblastic leukemia in the United States. Abstract

  26. A Structural Racism Framework to Guide Health Equity Interventions in Pediatric Oncology. Pediatrics. 2022 05 01; 149(5). View A Structural Racism Framework to Guide Health Equity Interventions in Pediatric Oncology. Abstract

  27. Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia. Infect Control Hosp Epidemiol. 2023 02; 44(2):222-229. View Risk of bacterial bloodstream infection does not vary by central-line type during neutropenic periods in pediatric acute myeloid leukemia. Abstract

  28. Missing Voices: Lessons Learned from Nonparticipating Caregivers in Palliative Care Research. J Palliat Med. 2022 03; 25(3):455-460. View Missing Voices: Lessons Learned from Nonparticipating Caregivers in Palliative Care Research. Abstract

  29. Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia. JAMA Netw Open. 2021 10 01; 4(10):e2128385. View Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia. Abstract

  30. Disparities in pediatric psychosocial oncology utilization. Pediatr Blood Cancer. 2021 11; 68(11):e29342. View Disparities in pediatric psychosocial oncology utilization. Abstract

  31. Pediatric Palliative Care Parents' Distress, Financial Difficulty, and Child Symptoms. J Pain Symptom Manage. 2022 02; 63(2):271-282. View Pediatric Palliative Care Parents' Distress, Financial Difficulty, and Child Symptoms. Abstract

  32. Naming the Problem: A Structural Racism Framework to Examine Disparities in Palliative Care. J Pain Symptom Manage. 2022 05; 63(5):e461-e463. View Naming the Problem: A Structural Racism Framework to Examine Disparities in Palliative Care. Abstract

  33. Race, ethnicity, and goal-concordance of end-of-life palliative care in pediatric oncology. Cancer. 2021 10 15; 127(20):3893-3900. View Race, ethnicity, and goal-concordance of end-of-life palliative care in pediatric oncology. Abstract

  34. PediCARE: Development of a poverty-targeted intervention for pediatric cancer. Pediatr Blood Cancer. 2021 10; 68(10):e29195. View PediCARE: Development of a poverty-targeted intervention for pediatric cancer. Abstract

  35. Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer. Am Soc Clin Oncol Educ Book. 2021 Jun; 41:e315-e326. View Disparities in Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for Children and Adolescents With Cancer. Abstract

  36. Socioeconomic disparities in survival after high-risk neuroblastoma treatment with modern therapy. Pediatr Blood Cancer. 2021 10; 68(10):e29127. View Socioeconomic disparities in survival after high-risk neuroblastoma treatment with modern therapy. Abstract

  37. Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology. Cancer Med. 2021 Apr; 10(7):2310-2318. View Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology. Abstract

  38. Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma. J Natl Cancer Inst. 2021 03 01; 113(3):282-291. View Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma. Abstract

  39. Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis. Blood. 2021 01 28; 137(4):556-568. View Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis. Abstract

  40. Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials. JAMA Oncol. 2020 09 01; 6(9):1465-1468. View Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials. Abstract

  41. Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials. JAMA Oncol. 2020 Aug 06. View Race Disparities in Proton Radiotherapy Use for Cancer Treatment in Patients Enrolled in Children's Oncology Group Trials. Abstract

  42. Off-label prescribing of targeted anticancer therapy at a large pediatric cancer center. Cancer Med. 2020 09; 9(18):6658-6666. View Off-label prescribing of targeted anticancer therapy at a large pediatric cancer center. Abstract

  43. Examining key sociodemographic characteristics of adolescents and young adults with cancer: A post hoc analysis of the Promoting Resilience in Stress Management randomized clinical trial. Palliat Med. 2020 03; 34(3):336-348. View Examining key sociodemographic characteristics of adolescents and young adults with cancer: A post hoc analysis of the Promoting Resilience in Stress Management randomized clinical trial. Abstract

  44. Distress and resilience among adolescents and young adults with cancer and their mothers: An exploratory analysis. J Psychosoc Oncol. 2020 Jan-Feb; 38(1):118-124. View Distress and resilience among adolescents and young adults with cancer and their mothers: An exploratory analysis. Abstract

  45. Pediatric Palliative Care in the Multicultural Context: Findings From a Workshop Conference. J Pain Symptom Manage. 2019 04; 57(4):846-855.e2. View Pediatric Palliative Care in the Multicultural Context: Findings From a Workshop Conference. Abstract

  46. The relationship between household income and patient-reported symptom distress and quality of life in children with advanced cancer: A report from the PediQUEST study. Cancer. 2018 10 01; 124(19):3934-3941. View The relationship between household income and patient-reported symptom distress and quality of life in children with advanced cancer: A report from the PediQUEST study. Abstract

  47. What we did not learn from an exploratory analysis of economic hardship in newly diagnosed adolescents and young adults with cancer. Pediatr Blood Cancer. 2018 Dec; 65(12):e27411. View What we did not learn from an exploratory analysis of economic hardship in newly diagnosed adolescents and young adults with cancer. Abstract

  48. Feasibility of systematic poverty screening in a pediatric oncology referral center. Pediatr Blood Cancer. 2018 12; 65(12):e27380. View Feasibility of systematic poverty screening in a pediatric oncology referral center. Abstract

  49. An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Pediatr Hematol Oncol. 2018 Mar; 35(2):95-110. View An overview of disparities in childhood cancer: Report on the Inaugural Symposium on Childhood Cancer Health Disparities, Houston, Texas, 2016. Abstract

  50. Hope, distress, and later quality of life among adolescent and young adults with cancer. J Psychosoc Oncol. 2018 Mar-Apr; 36(2):137-144. View Hope, distress, and later quality of life among adolescent and young adults with cancer. Abstract

  51. Disparities in Pediatric Palliative Care: An Opportunity to Strive for Equity. Pediatrics. 2017 10; 140(4). View Disparities in Pediatric Palliative Care: An Opportunity to Strive for Equity. Abstract

  52. Household material hardship in families of children post-chemotherapy. Pediatr Blood Cancer. 2018 Jan; 65(1). View Household material hardship in families of children post-chemotherapy. Abstract

  53. The Benefits and Burdens of Cancer: A Prospective Longitudinal Cohort Study of Adolescents and Young Adults. J Palliat Med. 2017 05; 20(5):494-501. View The Benefits and Burdens of Cancer: A Prospective Longitudinal Cohort Study of Adolescents and Young Adults. Abstract

  54. Intimacy, Substance Use, and Communication Needs During Cancer Therapy: A Report From the "Resilience in Adolescents and Young Adults" Study. J Adolesc Health. 2017 01; 60(1):93-99. View Intimacy, Substance Use, and Communication Needs During Cancer Therapy: A Report From the "Resilience in Adolescents and Young Adults" Study. Abstract

  55. The benefits and burdens of cancer: A prospective, longitudinal cohort study of adolescents and young adults. J Clin Oncol. 2016 Oct 09; 34(26_suppl):243. View The benefits and burdens of cancer: A prospective, longitudinal cohort study of adolescents and young adults. Abstract

  56. Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016 08; 22(8):1504-1510. View Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation. Abstract

  57. The Power of Personal Narrative: A Reply to "The Reality of Relapse: Impact of Cancer Relapse on Survivorship Interventions and Patient-Reported Outcomes Data". Pediatr Blood Cancer. 2016 08; 63(8):1494. View The Power of Personal Narrative: A Reply to "The Reality of Relapse: Impact of Cancer Relapse on Survivorship Interventions and Patient-Reported Outcomes Data". Abstract

  58. Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010). Pediatr Blood Cancer. 2016 Jun; 63(6):1012-8. View Impact of Socioeconomic Status on Timing of Relapse and Overall Survival for Children Treated on Dana-Farber Cancer Institute ALL Consortium Protocols (2000-2010). Abstract

  59. Adolescent and Young Adult Patient Engagement and Participation in Survey-Based Research: A Report From the "Resilience in Adolescents and Young Adults With Cancer" Study. Pediatr Blood Cancer. 2016 Apr; 63(4):734-6. View Adolescent and Young Adult Patient Engagement and Participation in Survey-Based Research: A Report From the "Resilience in Adolescents and Young Adults With Cancer" Study. Abstract

  60. Assessment of Financial Burden as a Standard of Care in Pediatric Oncology. Pediatr Blood Cancer. 2015 Dec; 62 Suppl 5:S619-31. View Assessment of Financial Burden as a Standard of Care in Pediatric Oncology. Abstract

  61. Trajectory of Material Hardship and Income Poverty in Families of Children Undergoing Chemotherapy: A Prospective Cohort Study. Pediatr Blood Cancer. 2016 Jan; 63(1):105-11. View Trajectory of Material Hardship and Income Poverty in Families of Children Undergoing Chemotherapy: A Prospective Cohort Study. Abstract

  62. Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Biol Blood Marrow Transplant. 2015 Feb; 21(2):312-8. View Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Abstract

  63. Economic impact of advanced pediatric cancer on families. J Pain Symptom Manage. 2014 Mar; 47(3):594-603. View Economic impact of advanced pediatric cancer on families. Abstract

  64. Massachusetts' Pediatric Palliative Care Network: successful implementation of a novel state-funded pediatric palliative care program. J Palliat Med. 2011 Nov; 14(11):1217-23. View Massachusetts' Pediatric Palliative Care Network: successful implementation of a novel state-funded pediatric palliative care program. Abstract

  65. Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer. J Clin Oncol. 2011 Mar 10; 29(8):1007-13. View Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer. Abstract

  66. Diagnosis and management of adults with pharyngitis. A cost-effectiveness analysis. Ann Intern Med. 2003 Jul 15; 139(2):113-22. View Diagnosis and management of adults with pharyngitis. A cost-effectiveness analysis. Abstract

BESbswy